IR Biosciences Holdings Net Income
| IRBSDelisted Stock | USD 0.0001 0.00 0.00% |
IR Biosciences Holdings technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
IR Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing IR Biosciences' valuation are provided below:IR Biosciences Holdings does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. IRBS |
Search Suggestions
| IR | Ingersoll Rand | Company |
| IRCAX | Voya Retirement Servative | Mutual Fund |
| IRE | Tidal Trust II | ETF |
| IRX | CBOE 13 Week | Index |
| IRYS | Irys | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, IR Biosciences Holdings reported net income of (5.28 Million). This is 106.93% lower than that of the Biotechnology sector and 14.91% higher than that of the Health Care industry. The net income for all United States stocks is 100.92% higher than that of the company.
IRBS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IR Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IR Biosciences could also be used in its relative valuation, which is a method of valuing IR Biosciences by comparing valuation metrics of similar companies.IR Biosciences is currently under evaluation in net income category among its peers.
IRBS Fundamentals
| Return On Asset | -7.92 | |||
| Current Valuation | 170.83 K | |||
| Shares Outstanding | 17.08 M | |||
| EBITDA | (2.85 M) | |||
| Net Income | (5.28 M) | |||
| Total Debt | 3.61 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.78) X | |||
| Cash Flow From Operations | (430.31 K) | |||
| Target Price | 2.0 | |||
| Beta | 527.47 | |||
| Market Capitalization | 213.54 K | |||
| Total Asset | 65.8 K | |||
| Working Capital | (6.46 M) | |||
| Current Asset | 45 K | |||
| Current Liabilities | 6.51 M | |||
| Net Asset | 65.8 K |
About IR Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IR Biosciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IR Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IR Biosciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in IRBS Stock
If you are still planning to invest in IR Biosciences Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IR Biosciences' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |